Endo International Stock Analysis (NASDAQ:ENDP)

Add to My Stocks
$11.31 $0.24 (2.08%) ENDP stock closing price Jul 26, 2017 (Closing)
Watch Robo Advisor Video of ENDP Stock Analysis
Endo International
Updated on : Jul 26, 2017
previous close
ENDP 11.3 (0%)
S&P 500 2477.8 (0%)
Closing Price On: Jul 26, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Drugs
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q1
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-84.4%
Sector Average:
-0.5%
5 Quarter Net Profit
Net Margins
2017-Q1
%
LTM Margin
Debt/Equity Ratio
Debt:
8.25B
Debt/Equity Ratio:
 3.77
Compared to the industry
Cash Flow
Operating cash flow:
$167.8M
Net Income:
-$173.8M
PROS      CONS
Recent Growth
FCF Margin
PE Valuation
PS Valuation
Operating Margins
Net Margins
High Debt Burden
ROIC
ROE
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
ENDP PS :
0.6
Industry PS :
5.2
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
-23.1%
Return on Equity:
-73.2%
Free Cash Flow Margin:
13.5%
Double Tap To Exit Full Screen
0:00
/

Endo International Analysis Video

321 6 2

View Endo International stock analysis video. This is our ENDP analyst opinion covering the buy and sell arguments for ENDP stock.

Endo International plc - Ordinary Shares Stock Rating (2.7/5)

Our Endo International stock opinion is based on fundamentals of the company. This Endo International stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy ENDP stock?

  • The Year Over Year (YoY) revenue growth for Endo International was 7.7% in 2017 Q1.
  • The price to earnings multiple of 2.3 is attractive when compared with the industry average PE ratio of 24.4.
  • The lower PS ratio 0.6 for ENDP stock versus Medical-Drugs industry average of 5.2 is a positive for the company.
  • The company has a good Free Cash Flow (FCF) margin of 13.5%.

Should you sell ENDP stock?

  • Endo International registered a negative operating margin of -84.4% (average) over the Trailing Twelve Months (TTM).
  • Over the last 12 months, Endo International had an average Net loss of -82.9%.
  • With a debt/equity ratio of  3.77, Endo International is highly leveraged in comparison to Medical peers.
  • Endo International's negative ROIC of -23.1% indicates operational inefficiency.
  • Endo International has a negative ROE (Return On Equity) of -73.2%, indicating the company is not profitable.

Comments on this video and Endo International stock